rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Rediff News  All News 

Dcgi

Rediff.com  »  News  »   Dcgi

  News for Dcgi

  • News
  • Business

Never spoke about vaccinating entire country: Govt

The Centre on Tuesday said there may not be a need to vaccinate the country's entire population against COVID-19 if a critical mass of people are given a shot to break the chain of virus......

Adverse event won't affect Covid vaccine's timeline: Govt

The initial findings into an 'adverse event' allegedly suffered by an Oxford COVID-19 vaccine trial participant in Chennai did not necessitate halting of the trials, the Centre said on Tuesday. It......

Incident with volunteer no way induced by vaccine: Serum Institute

Stressing that the Covishield vaccine is "safe and immunogenic", the Serum Institute of India on Tuesday said the incident with the Chennai volunteer was in no way induced by the vaccine as......

Covid vaccine participant alleges side effects, seeks Rs 5 cr from Serum

A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and......

RDIF, Hetero to produce over 100 mn doses of Russian vaccine in India

Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth......

How complex is the process of getting approval for a vaccine?

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through......

Pandemic brings windfall for e-pharma companies

The online pharmacy market, which was worth about $512 million in 2018, is growing at a CAGR of 63 per cent and is expected to hit overall revenues of over $3.6 billion by 2022. Illustration:......

Dr Reddy's launches COVID-19 drug Avigan

Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life. Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (favipiravir) 200 mg tablets in India. The......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease. Joining the long list of firms to launch its own......
  Videos for Dcgi
dcgi video
dcgi video
  Web results for Dcgi
Covid-19 vaccine trial volunteer alleges side effects; DCGI and ethics committee probing matter; Serum Institute rejects charge

Serum Institute rejects charges levelled by vaccine trial participant, threatens to seek damages Serum Institute rejects charges levelled by... ...

https://timesofindia.indiatimes.com/india/serum-institute-rejects-charges-levelled-by-vaccine-trial-participant-threatens-to-seek-damages/articleshow/79478175.cms
DCGI and institutional ethics committee investigating claim of adverse event in COVID vaccine trial

A 40-year-old Chennai-based business consultant, who was a volunteer for the third phase of the vaccine trial conducted by Pune-based Serum... ...

https://economictimes.indiatimes.com/news/politics-and-nation/dcgi-and-institutional-ethics-committee-investigating-claim-of-adverse-event-in-covid-vaccine-trial/articleshow/79475211.cms
ICMR says will wait for DCGI call on adverse event report involving Covid-19 vaccine

The Indian Council of Medical Research (ICMR) has said it will wait for the Drug Controller General of India (DCGI) to take a call on the adverse even ...

https://www.thehindubusinessline.com/news/icmr-says-will-wait-for-dcgi-call-on-adverse-event-report-involving-covid-19-vaccine/article33202240.ece
Poonawalla

SII plans to apply for emergency use authorization for AstraZeneca's COVID-19 vaccine candidate that he described as a "very good" option. MUMBAI:... ...

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/serum-institute-in-talks-with-indian-govt-on-pricing-distribution-of-covid-vaccines/articleshow/79465514.cms
RDIF, Hetero to produce over 100 mn doses of Russian vaccine in India

Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V... ...

http://www.rediff.com/news/report/rdif-hetero-to-make-100-mn-doses-of-russian-vaccine/20201127.htm

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z